Consulting and support in nonclinical and early clinical drug development including drug discovery and preclinical safety processes from target identification/validation, lead candidates, pharmacology, toxicology, project planning, monitoring, interpreting, and reporting. Transition between preclinical and early clinical development.
I have fulfilled a number of scientific and management tasks in drug-development in pharmaceutical industry focused on development of novel therapies for infectious diseases, cancer, diabetes and inflammation. I have experience from immunology research, translational research and safety assessment, from a scientific perspective as well as from project-management perspectives.